Tenaya Therapeutics Inc (nasdaq:TNYA) Share Price

Company Profile

Business description
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Contact
171 Oyster Point Boulevard
Suite 500, 5th Floor
South San FranciscoCA94080
USA
T: +1 650 825-6990
https://www.tenayatherapeutics.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
70

Recommended

Discounted exit raises investor concerns.

Yingqi Tan, CFA | 21 September 2026

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Jacob Robbins | 21 September 2026

Morningstar analysts’ take on the takeover for this undervalued industrial player.

Esther Holloway | 20 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,951.00	31.90	0.36%
CAC 40	8,139.45	0.51	0.01%
DAX 40	25,485.37	89.64	-0.35%
Dow JONES (US)	52,048.83	366.19	0.71%
FTSE 100	10,726.48	12.53	-0.12%
HKSE	25,051.99	9.28	0.04%
NASDAQ	27,122.09	599.55	2.26%
Nikkei 225	65,018.95	882.70	1.38%
NZX 50 Index	13,875.48	54.28	0.39%
S&P 500	7,764.70	114.20	1.49%
S&P/ASX 200	8,757.80	25.90	0.30%
SSE Composite Index	3,952.13	2.22	0.06%